| We are building a portfolio of promising drug candidates and forging innovative partnerships in order to deliver a new anti-tuberculosis drug in a decade.
A not-for-profit enterprise, we enlist the best practices, science and resources of the private and public sectors the world over to meet this urgent health need.
Our mission is to ensure equitable access to a faster tuberculosis cure that will advance global health and prosperity. Based in New York, Brussels and Cape Town, we work with partners, stakeholders and other allies worldwide. |
